Clinical trial
Gemcitabine in Combination With Either Cisplatin or Carboplatin in Treating…
NCT00112710 · University Hospital Birmingham, Other · Unknown status
Key facts
| NCT number | NCT00112710 |
|---|---|
| Title | Gemcitabine in Combination With Either Cisplatin or Carboplatin in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer |
| Official title | A British Thoracic Oncology Group Phase III Trial of Gemcitabine Plus Cisplatin at 80mg/m Versus Gemcitabine Plus Carboplatin At 50 mg/m Versus Gemcitabine Plus Carboplatin AUC 6 in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) |
| Lead sponsor | University Hospital Birmingham, Other |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Lung Cancer |
| Intervention type | Drug |
| Interventions | carboplatin, cisplatin, gemcitabine hydrochloride |
| Enrollment | 1,350 |
| Start date | Mar 1, 2005 |
| First posted | Jun 3, 2005 |
| Last update posted | Aug 26, 2013 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: